Resource utilization and outcomes in emergency general surgery during the COVID19 pandemic: An observational cost analysis.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 14 04 2021
accepted: 25 05 2021
entrez: 18 6 2021
pubmed: 19 6 2021
medline: 11 11 2021
Statut: epublish

Résumé

Over the course of the COVID19 pandemic, global healthcare delivery has declined. Surgery is one of the most resource-intensive area of medicine; loss of surgical care has had untold health and economic consequences. Herein, we evaluate resource utilization, outcomes, and healthcare costs associated with unplanned surgery admissions during the height of the pandemic in 2020 versus the same period in 2019. Retrospective analysis on patients ≥18 years admitted from the emergency department to General & Digestive and Gastrointestinal Surgery Services between February and May 2019 and 2020 at our center; clinical outcomes and unadjusted and adjusted per-person healthcare costs were analyzed. Consults and admissions to surgery declined between February and May 2020 by 37% and 19%, respectively, relative to the same period in 2019, with even greater relative decline during late March and early April. Time between onset of symptoms to diagnosis increased from 2±3 days 2019 to 5±22 days 2020 (P = 0.01). Overall hospital stay was two days less in 2020 (P = 0.19). Complications (Comprehensive Complication Index 10.3±23.7 2019 vs. 13.9±25.5 2020, P = 0.10) and mortality rates (3% vs. 4%, respectively, P = 0.58) did not vary. Mean unadjusted per-person costs for patients in the 2019 and 2020 cohorts were 5,886.72€±12,576.33€ and 5,287.62±7,220.16€, respectively (P = 0.43). Following multivariate analysis, costs remained similar (4,656.89€±390.53€ 2019 vs. 4,938.54±406.55€ 2020, P = 0.28). Healthcare delivery and spending for unplanned general surgery admissions declined considerably due to COVID19. These results provide a small yet relevant illustration of clinical and economic ramifications of this healthcare crisis.

Sections du résumé

BACKGROUND
Over the course of the COVID19 pandemic, global healthcare delivery has declined. Surgery is one of the most resource-intensive area of medicine; loss of surgical care has had untold health and economic consequences. Herein, we evaluate resource utilization, outcomes, and healthcare costs associated with unplanned surgery admissions during the height of the pandemic in 2020 versus the same period in 2019.
METHODS
Retrospective analysis on patients ≥18 years admitted from the emergency department to General & Digestive and Gastrointestinal Surgery Services between February and May 2019 and 2020 at our center; clinical outcomes and unadjusted and adjusted per-person healthcare costs were analyzed.
RESULTS
Consults and admissions to surgery declined between February and May 2020 by 37% and 19%, respectively, relative to the same period in 2019, with even greater relative decline during late March and early April. Time between onset of symptoms to diagnosis increased from 2±3 days 2019 to 5±22 days 2020 (P = 0.01). Overall hospital stay was two days less in 2020 (P = 0.19). Complications (Comprehensive Complication Index 10.3±23.7 2019 vs. 13.9±25.5 2020, P = 0.10) and mortality rates (3% vs. 4%, respectively, P = 0.58) did not vary. Mean unadjusted per-person costs for patients in the 2019 and 2020 cohorts were 5,886.72€±12,576.33€ and 5,287.62±7,220.16€, respectively (P = 0.43). Following multivariate analysis, costs remained similar (4,656.89€±390.53€ 2019 vs. 4,938.54±406.55€ 2020, P = 0.28).
CONCLUSIONS
Healthcare delivery and spending for unplanned general surgery admissions declined considerably due to COVID19. These results provide a small yet relevant illustration of clinical and economic ramifications of this healthcare crisis.

Identifiants

pubmed: 34143802
doi: 10.1371/journal.pone.0252919
pii: PONE-D-21-12253
pmc: PMC8213049
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0252919

Déclaration de conflit d'intérêts

Amelia J. Hessheimer and Constantino Fondevila have received consultancy fees from Guanguong Shunde Innovative Design Institute, Guangdong, China, and research funding from Instituto de Salud Carlos III. This does not alter their adherence to PLOS ONE policies on sharing data and materials. The remainder of authors have no disclosures.

Références

JAMA. 2020 Nov 3;324(17):1713-1714
pubmed: 33141199
Ann Surg. 2018 Nov;268(5):784-791
pubmed: 30272585
BMJ Glob Health. 2020 Nov;5(11):
pubmed: 33184065
Am J Emerg Med. 2021 Aug;46:476-481
pubmed: 33189517
J Health Econ. 2001 Jul;20(4):461-94
pubmed: 11469231
JAMA. 2020 Oct 27;324(16):1596-1597
pubmed: 33107930
Ann Surg. 2013 Jul;258(1):1-7
pubmed: 23728278
Int J Environ Res Public Health. 2020 Dec 27;18(1):
pubmed: 33375442
Ann Med Surg (Lond). 2020 Dec;60:5-8
pubmed: 33072312
Br J Health Psychol. 2021 May;26(2):624-643
pubmed: 33410229
Obes Sci Pract. 2020 Aug 12;6(6):735-740
pubmed: 33354349
Popul Health Manag. 2020 Oct;23(5):378-385
pubmed: 32810418
N Z Med J. 2020 Nov 20;133(1525):96-105
pubmed: 33223552
J Neurosurg Anesthesiol. 2021 Jul 1;33(3):268-272
pubmed: 33229942
Med Care. 2021 Jan;59(1):58-61
pubmed: 33136711
Emergencias. 2020 Nov;32(6):435-436
pubmed: 33275368
Surgeon. 2021 Oct;19(5):e207-e212
pubmed: 33257272
Environ Sci Technol. 2015 Feb 3;49(3):1779-86
pubmed: 25517602
Br J Surg. 2020 Oct;107(11):e545-e546
pubmed: 32866298
J Visc Surg. 2021 Feb;158(1):94-95
pubmed: 33243727
Am Surg. 2020 Dec;86(12):1629-1635
pubmed: 33231486
Updates Surg. 2020 Dec;72(4):1041-1051
pubmed: 32734578

Auteurs

Amelia J Hessheimer (AJ)

General & Digestive Surgery, Institut de Malaties Digestives i Metabòliques (ICMDM), Hospital Clínic Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.

Marta Trapero-Bertran (M)

Basic Sciences Department, University Institute for Patient Care, Universitat Internacional de Catalunya Barcelona, Barcelona, Spain.

Alex Borin (A)

General & Digestive Surgery, ICMDM, Hospital Clínic Barcelona, Barcelona, Spain.

Eugenia Butori (E)

General & Digestive Surgery, ICMDM, Hospital Clínic Barcelona, Barcelona, Spain.
Gastrointestinal Surgery, ICMDM, Hospital Clínic Barcelona, Barcelona, Spain.

Anna Curell (A)

Gastrointestinal Surgery, ICMDM, Hospital Clínic Barcelona, Barcelona, Spain.

Arlena Sofía Espinoza (AS)

General & Digestive Surgery, ICMDM, Hospital Clínic Barcelona, Barcelona, Spain.
Gastrointestinal Surgery, ICMDM, Hospital Clínic Barcelona, Barcelona, Spain.

Joaquín Jensen (J)

General & Digestive Surgery, ICMDM, Hospital Clínic Barcelona, Barcelona, Spain.

Víctor Turrado (V)

Gastrointestinal Surgery, ICMDM, Hospital Clínic Barcelona, Barcelona, Spain.

Xavier Morales (X)

Gastrointestinal Surgery, ICMDM, Hospital Clínic Barcelona, Barcelona, Spain.

Antonio María de Lacy (AM)

Gastrointestinal Surgery, ICMDM, Hospital Clínic Barcelona, Barcelona, Spain.

Constantino Fondevila (C)

General & Digestive Surgery, Institut de Malaties Digestives i Metabòliques (ICMDM), Hospital Clínic Barcelona, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH